CN113109329A - Clinical test sample kit convenient for comparison and use method thereof - Google Patents
Clinical test sample kit convenient for comparison and use method thereof Download PDFInfo
- Publication number
- CN113109329A CN113109329A CN202110375190.5A CN202110375190A CN113109329A CN 113109329 A CN113109329 A CN 113109329A CN 202110375190 A CN202110375190 A CN 202110375190A CN 113109329 A CN113109329 A CN 113109329A
- Authority
- CN
- China
- Prior art keywords
- piece
- detection
- observation
- shell
- needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 79
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- 238000003780 insertion Methods 0.000 claims abstract description 17
- 230000037431 insertion Effects 0.000 claims abstract description 17
- 239000002775 capsule Substances 0.000 claims description 49
- 239000003153 chemical reaction reagent Substances 0.000 claims description 38
- 238000001125 extrusion Methods 0.000 claims description 30
- 238000005452 bending Methods 0.000 claims description 23
- 238000007789 sealing Methods 0.000 claims description 15
- 102100025825 Methylated-DNA-protein-cysteine methyltransferase Human genes 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 108040008770 methylated-DNA-[protein]-cysteine S-methyltransferase activity proteins Proteins 0.000 claims description 12
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 11
- -1 polytetrafluoroethylene Polymers 0.000 claims description 7
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 7
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000001746 injection moulding Methods 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 230000006835 compression Effects 0.000 claims description 3
- 238000007906 compression Methods 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 238000006073 displacement reaction Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims 1
- 238000013461 design Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 206010041823 squamous cell carcinoma Diseases 0.000 description 6
- 206010061534 Oesophageal squamous cell carcinoma Diseases 0.000 description 5
- 208000036765 Squamous cell carcinoma of the esophagus Diseases 0.000 description 5
- 208000007276 esophageal squamous cell carcinoma Diseases 0.000 description 5
- 230000006607 hypermethylation Effects 0.000 description 5
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 201000004101 esophageal cancer Diseases 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 102000011724 DNA Repair Enzymes Human genes 0.000 description 1
- 108010076525 DNA Repair Enzymes Proteins 0.000 description 1
- 101000931098 Homo sapiens DNA (cytosine-5)-methyltransferase 1 Proteins 0.000 description 1
- 101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 description 1
- 101150042248 Mgmt gene Proteins 0.000 description 1
- 102000013609 MutL Protein Homolog 1 Human genes 0.000 description 1
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N2021/0106—General arrangement of respective parts
- G01N2021/0112—Apparatus in one mechanical, optical or electronic block
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110375190.5A CN113109329B (en) | 2021-04-08 | 2021-04-08 | Clinical test sample kit convenient for comparison and use method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110375190.5A CN113109329B (en) | 2021-04-08 | 2021-04-08 | Clinical test sample kit convenient for comparison and use method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113109329A true CN113109329A (en) | 2021-07-13 |
CN113109329B CN113109329B (en) | 2022-05-10 |
Family
ID=76714226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110375190.5A Expired - Fee Related CN113109329B (en) | 2021-04-08 | 2021-04-08 | Clinical test sample kit convenient for comparison and use method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113109329B (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106264563A (en) * | 2016-09-22 | 2017-01-04 | 东莞市联洲知识产权运营管理有限公司 | A kind of novel blood collector |
CN206258463U (en) * | 2016-11-03 | 2017-06-16 | 徐立然 | A kind of AIDS detection kit |
CN110786867A (en) * | 2019-09-23 | 2020-02-14 | 南京市儿童医院 | Negative pressure blood taking needle capable of preventing blood from coagulating |
CN110916683A (en) * | 2019-12-13 | 2020-03-27 | 肖颖宾 | Automatic blood sampler for fingers of clinical laboratory |
CN211155825U (en) * | 2019-11-11 | 2020-08-04 | 袁凌伟 | Neonate's heel blood sampling negative pressure hemospast |
CN212646710U (en) * | 2020-07-25 | 2021-03-02 | 武汉康德庆生物科技有限公司 | Sampling test integral type antibody detect reagent box |
CN212661814U (en) * | 2020-04-26 | 2021-03-09 | 顾少亮 | Negative pressure drainage mechanism and blood sampling device |
-
2021
- 2021-04-08 CN CN202110375190.5A patent/CN113109329B/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106264563A (en) * | 2016-09-22 | 2017-01-04 | 东莞市联洲知识产权运营管理有限公司 | A kind of novel blood collector |
CN206258463U (en) * | 2016-11-03 | 2017-06-16 | 徐立然 | A kind of AIDS detection kit |
CN110786867A (en) * | 2019-09-23 | 2020-02-14 | 南京市儿童医院 | Negative pressure blood taking needle capable of preventing blood from coagulating |
CN211155825U (en) * | 2019-11-11 | 2020-08-04 | 袁凌伟 | Neonate's heel blood sampling negative pressure hemospast |
CN110916683A (en) * | 2019-12-13 | 2020-03-27 | 肖颖宾 | Automatic blood sampler for fingers of clinical laboratory |
CN212661814U (en) * | 2020-04-26 | 2021-03-09 | 顾少亮 | Negative pressure drainage mechanism and blood sampling device |
CN212646710U (en) * | 2020-07-25 | 2021-03-02 | 武汉康德庆生物科技有限公司 | Sampling test integral type antibody detect reagent box |
Also Published As
Publication number | Publication date |
---|---|
CN113109329B (en) | 2022-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109372731A (en) | Peristaltic pump | |
CN2936144Y (en) | Blood-taking holder | |
CN111876318A (en) | Closed chromatography test paper card box | |
CN113109329B (en) | Clinical test sample kit convenient for comparison and use method thereof | |
CN213779983U (en) | Kit for detecting multiple steroid hormones in blood sample | |
CN114525202A (en) | Closed detection card for detecting new coronavirus | |
CN217836634U (en) | Anti-pollution nucleic acid detecting tube of prevention of liquid leakage | |
CN218035799U (en) | Portable integrated sampling detection tube | |
CN112229932A (en) | Method and kit for detecting multiple steroid hormones in blood sample | |
CN219871362U (en) | Quick detection device for detecting total serum proteins for screening pneumonia of COVID-19 viruses | |
CN212780832U (en) | Pathogen and antibody detection device | |
CN214965643U (en) | Blood collection tube for clinical examination | |
CN218752123U (en) | Novel medical detection kit | |
CN216816151U (en) | Sealed urine collecting device convenient to disassemble and assemble | |
CN220999638U (en) | Top core thorn membrane pipetting system | |
CN114085745B (en) | Gene detection kit | |
CN218290909U (en) | Nucleic acid detection collection tube | |
CN212844404U (en) | Medical clinical laboratory health sampling device | |
CN220265659U (en) | Device for preventing aerosol pollution | |
CN220967321U (en) | Portable integral type sample detection tube | |
CN215906202U (en) | Sampling device for cell detection | |
CN218766942U (en) | Reagent detection device | |
CN214991586U (en) | Integrative device that nucleic acid short-term test drawed and fluorescence amplification detected | |
CN114534312B (en) | PRP separator | |
CN215688077U (en) | Improved detection puncture needle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 650000 4th floor, building 47, Dongfeng East Road, Kunming, Yunnan Applicant after: Tian Hui Applicant after: Sun Zhenguo Address before: 250012 No. 107 west Wenhua Road, Lixia District, Shandong, Ji'nan Applicant before: Tian Hui Applicant before: Sun Zhenguo |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 250012 No. 107 west Wenhua Road, Lixia District, Shandong, Ji'nan Applicant after: Tian Hui Applicant after: Sun Zhenguo Address before: 650000 4th floor, building 47, Dongfeng East Road, Kunming, Yunnan Applicant before: Tian Hui Applicant before: Sun Zhenguo |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220510 |
|
CF01 | Termination of patent right due to non-payment of annual fee |